Skip to main content

Erratum to: A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1

The Original Article was published on 20 September 2016

Erratum

Unfortunately, after publication of this article [1], it was noticed that the name of the second author was incorrectly displayed as Faa’k Faisal. The correct name is Faisal Fa’ak and can be seen in the corrected author list above. The original article has also been updated to correct this error.

Reference

  1. Uemura M, Fa’ak F, Haymaker C, McQuail N, Sirmans E, Hudgens CW, Barbara L, Bernatchez C, Curry JL, Hwu P, Tetzlaff MT, Diab A. A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1. J Immunother Cancer. 2016;4:55. http://doi.org/10.1186/s40425-016-0157-6.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adi Diab.

Additional information

The online version of the original article can be found under doi:10.1186/s40425-016-0157-6.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uemura, M., Fa’ak, F., Haymaker, C. et al. Erratum to: A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1. j. immunotherapy cancer 5, 7 (2017). https://doi.org/10.1186/s40425-017-0208-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40425-017-0208-7